Unfortunately, there are many pets with cancer.

 
 
 
insight-0101.png
insight-01.png
 
 
insight-0202.png
insight-02.png
 
 
insight-0303.png
insight-03.png
 
 
 

Every human cancer patient shows a different response to a drug. So do our dogs and cats.

We need to personalize treatment for our pet cancer patients.

 
patrick-hendry-547735.jpg

Our Approach

 

We look into drug responses of patient’s live cancer cells before treatment. ImpriMed’s personalized drug testing service helps veterinary oncologists decide a final treatment regimen based on our data-driven technology for response success in each individual patient body.

 
 
approach.png
 

Benefits of our service

 
 
eric-cat-ward-610868.jpg

Pet patients

Receive the drugs that work best, and avoid the ones that may not work

eric-ward-610868.jpg

Pet parents

Extend quality of life with your pets and reduce cost by excluding treatment options that may not work

 
 
 
puppy-919223_1280.jpg

Veterinary oncologists

Provide a more tailored treatment based on data-driven test results for each individual patient

brown-white-dogs_925x.jpg

Veterinary hospitals

Improve reputation through better patient care and generate additional revenue from increased patient traction and sales margin

 
 
 

"There are so many similarities between the cancers we see in dogs and the cancers we see in people."

Karin Sorenmo
Professor of oncology at the UPenn School of Veterinary Medicine
Genome Magazine
 
adam-griffith-408788.jpg
 

Database

ImpriMed collects both gene and cell information directly from pets’ cancer cells. Our unique and extensive database will be translated into human oncology and also provide research insights into fighting human cancer.


"The study of new diagnostics and treatments for spontaneous cancer in pets has the potential to benefit our individual veterinary patients, animals with cancer as a whole, and, owing to their similarity, potentially shed new light into the diagnosis and therapy of human cancers as well. This is the basis of Comparative Oncology.”

Douglas H. Thamm
Director of Clinical Research at Flint Animal Cancer Center, Colorado State University

database.png
 
 

 

Meet your oncologists

Please discuss about the ImpriMed service with your veterinary oncologists in the following locations:

 
 
 

North California

SAGE Dublin
7121 Amador Plaza Rd, Dublin, CA 94568

SAGE Campbell
907 Dell Ave, Campbell, CA 95008

SAGE Redwood City
934 Charter St, Redwood City, CA 94063

SAGE Concord
1410 Monument Blvd, Concord, CA 94520

Silicon Valley Veterinary Specialist
7160 Santa Teresa Blvd, San Jose, CA 95139

AIMSS San Francisco
1333 9th Ave, San Francisco, CA 94122

AIMSS San Mateo
251 N. Amphlett Blvd. San Mateo, CA 94401

VCA San Francisco
600 Alabama St, San Francisco, CA 94110

VCA San Leandro
14790 Washington Ave, San Leandro, CA 94578

East Bay Veterinary Specialists & Emergency
2803 Ygnacio Valley Rd, Walnut Creek, CA 94598


Colorado

Flint Animal Cancer Center, Colorado State University
Flint Animal Cancer Center, Colorado State University, 300 West Drake Road, Fort Collins, CO 80523-1620

 
 
 

"You are treating patients who are dogs — at the same time, you can gather a lot of information from those studies that will be useful for other dogs and for humans as well."

Kerstin Lindblad-Toh
Professor in comparative genomics at the Broad Institute of Harvard and MIT
Genome Magazine
 
david-rangel-456755.jpg